Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 3—March 2020
Research Letter

Geographic Expansion of Sporotrichosis, Brazil

Figures
Article Metrics
Isabella Dib Ferreira GremiãoComments to Author , Manoel Marques Evangelista Oliveira, Luisa Helena Monteiro de Miranda, Dayvison Francis Saraiva Freitas, and Sandro Antonio Pereira
Author affiliations: Oswaldo Cruz Foundation, Rio de Janeiro, Brazil

Cite This Article

Abstract

Brazil has experienced geographic expansion of zoonotic sporotrichosis. Social problems in the country contribute substantially to the expansion. A comprehensive sporotrichosis control program is beyond the sphere of public health. A One Health approach is needed to control the disease in animals and humans.

High rates of human cases of sporotrichosis caused by Sporothrix brasiliensis transmitted by cats have been reported in Brazil since 1998 (1). The main referral center for the treatment of this mycotic disease, Oswaldo Cruz Foundation (Fiocruz) in Rio de Janeiro, recorded ≈5,000 human cases during 1998–2015 (D.F.S. Freitas, unpub. data) and 5,113 feline cases during 1998–2018 (S.A. Pereira, unpub. data). However, these numbers only represent cases diagnosed at 1 institution, and actual incidence rates likely are higher.

Figure

Thumbnail of Occurrence of feline sporotrichosis and cases of zoonotic transmission in Brazil. *Reference center is the Laboratory of Clinical Research on Dermatozoonoses in Domestic Animals, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Rio de Janeiro, Brazil. AC, Acre; AL, Alagoas; AM, Amazonas; AP, Amapá; BA, Bahia; CE, Ceará; DF, Federal District; ES, Espírito Santo; GO, Goiás; MA, Maranhão; MG, Minas Gerais; MS, Mato Grosso do S

Figure. Occurrence of feline sporotrichosis and cases of zoonotic transmission in Brazil. *Reference center is the Laboratory of Clinical Research on Dermatozoonoses in Domestic Animals, Evandro Chagas National Institute of Infectious Diseases,...

During 1998–2017, Brazil experienced a geographic expansion of sporotrichosis. The southeast region had the largest occurrence of human and animal cases (1,2), but outbreaks and case reports of feline sporotrichosis have been described from other regions (35) (Figure). In regions only reporting feline cases, zoonotic transmission probably is going unnoticed.

Zoonotic sporotrichosis also has been reported in the United States, India, Malaysia, Argentina, Mexico, and Panama (2). In Malaysia, isolates from cases caused by S. schenckii sensu stricto (6) have included clonal reproduction, which could indicate ongoing emergence of a genotype that is adapting to the feline host (7), similar to what was reported for S. brasiliensis in Brazil (1). Also, the occurrence of zoonotic sporotrichosis due to S. brasiliensis in Argentina is alarming because it points to a potential transboundary expansion of this virulent species to other regions in Latin America. Despite rules implemented for pet travel, poor control over road transportation might contribute to the spread of sporotrichosis in Brazil and could pose a risk for spread beyond its borders (8).

Fungal infections generally are neglected (9), and public health policies and strategic plans for prioritizing such infections are lacking. Inadequate surveillance of fungal infections leads to unnoticed emergence, such as seen with zoonotic sporotrichosis.

The rise and spread of sporotrichosis cases in Brazil were overlooked for several years, making a previously rare disease frequent and uncontrolled in many regions. Continuing socioeconomic and environmental difficulties, such as economic and social inequality, poverty, unemployment, urban agglomeration, and poor basic sanitation, coupled with scarce and inadequate health services, are fueling this expansion. In Rio de Janeiro, despite the high number of cases and the strain sporotrichosis puts on public health services, an animal sporotrichosis control program that included free diagnosis and treatment was not implemented until 16 years after the epidemic began. Nevertheless, given the chaotic situation in this region, the control measures used were insufficient. Even with the spread of the disease to other states in Brazil, compulsory notification is performed by only a few specific municipalities.

The absence of a comprehensive feline sporotrichosis control program in Brazil, the multifactorial difficulty in managing sick cats, and the lack of knowledge of sporotrichosis control measures by most of the population have contributed to the growing number of human and animal cases. A One Health approach is key for effective surveillance and successful control. Coordinated actions among veterinarians, laboratory practitioners, surveillance authorities, and other healthcare workers will ensure broader investigations and promote prevention, detection, and assistance for human and animal cases.

Early diagnosis of feline sporotrichosis is essential to guarantee appropriate prevention for owners, especially those at higher risk for infection, such as persons with immunosuppression. In addition, prompt treatment in felines can rapidly reduce the fungal load and risk for transmission of Sporothrix by cats (10). Thus, the availability of itraconazole, the first-line treatment for humans and animals, is essential in health units of affected areas.

The pattern of feline sporotrichosis appears to be changing in the world, with new cases of zoonotic transmission by other Sporothrix species appearing (1). Health authorities from neighboring countries should be aware of the signs and symptoms of disease to identify cases early and rapidly implement prevention and control measures. Atypical cases and treatment failures emphasize the need for studies focusing on the detection of potential antifungal resistance and alternative therapeutic strategies. The emergence of new species or changes in the behavior of known species also should be assessed, to identify variations in the ecoepidemiology and in host–pathogen interactions.

If health authorities in Rio de Janeiro had taken measures to control and prevent sporotrichosis in the feline population at the first appearance of human cases, the current scenario could be different and likely would have cost less to the health system in the long term. Considering the remarkable spread of sporotrichosis in the past decade, effective public health actions, including free medication and service for animals, are urgently needed to prevent additional cases in affected areas. We encourage a One Health approach to curb further expansion of sporotrichosis in humans and animals in Brazil.

Dr. Gremião is a veterinarian and researcher in the Laboratory of Clinical Research on Dermatozoonoses in Domestic Animals, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro. Her areas of interest include epidemiology, diagnosis, and treatment of fungal diseases in animals, including sporotrichosis and cryptococcosis.

Top

Acknowledgments

The authors thank the Laboratory of Clinical Research on Dermatozoonoses in Domestic Animals, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.

S.A.P. was supported in part by Jovem Cientista do Nosso Estado 2019 (JCNE) – FAPERJ (grant no. E-26/202.737/2019) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) (grant no. 309657/2016-4). M.M.E.O. was supported in part by FAPERJ (grant nos. INST E-26/010.001784/2016 and JCNE E-26/203.301/2017).

Top

References

  1. Lopes-Bezerra  LM, Mora-Montes  HM, Zhang  Y, Nino-Vega  G, Rodrigues  AM, de Camargo  ZP, et al. Sporotrichosis between 1898 and 2017: The evolution of knowledge on a changeable disease and on emerging etiological agents. Med Mycol. 2018;56(suppl_1):126–43.
  2. Gremião  ID, Miranda  LH, Reis  EG, Rodrigues  AM, Pereira  SA. Zoonotic Epidemic of Sporotrichosis: Cat to Human Transmission. PLoS Pathog. 2017;13:e1006077. DOIPubMed
  3. Fernandes  CGN, Moura  ST, Dantas  AFM, Blatt  MCS. Feline sporotrichosis–clinical and epidemiological aspects: case reports (Cuiabá, Mato Grosso, Brazil) [in Portuguese]. MedVep Rev Cient Med Vet Peq An. 2004;2:3943.
  4. Figueira  KD, Nunes  GDL. Feline sporotrichosis: first report in the city of Mossoró, Rio Grande do Norte, Brazil [in Portuguese]. MedVep Rev Cient Med Vet Peq An. 2010;8:7158.
  5. Silva  GM, Howes  JCF, Leal  CAS, Mesquita  EP, Pedrosa  CM, Oliveira  AAF, et al. Feline sporotrichosis outbreak in the metropolitan region of Recife [in Portuguese]. Pesqui Vet Bras. 2018;38:176771. DOI
  6. Kano  R, Okubo  M, Siew  HH, Kamata  H, Hasegawa  A. Molecular typing of Sporothrix schenckii isolates from cats in Malaysia. Mycoses. 2015;58:2204. DOIPubMed
  7. Siew  HH. The current status of feline sporotrichosis in Malaysia. Med Mycol J. 2017;58:E10713. DOIPubMed
  8. Ministry of Agriculture. Livestock and Food Supply, Brazil. Traveling with pets [in Portuguese]. 2017 Nov 24 [cited 2019 Nov 08]. http://www.agricultura.gov.br/assuntos/vigilancia-agropecuaria/animais-estimacao
  9. Seyedmousavi  S, Guillot  J, Tolooe  A, Verweij  PE, de Hoog  GS. Neglected fungal zoonoses: hidden threats to man and animals. Clin Microbiol Infect. 2015;21:41625. DOIPubMed
  10. de Miranda  LHM, Silva  JN, Gremião  IDF, Menezes  RC, Almeida-Paes  R, Dos Reis  EG, et al. Monitoring fungal burden and viability of Sporothrix spp. in skin lesions of cats for predicting antifungal treatment response. J Fungi (Basel). 2018;4:E92. DOIPubMed

Top

Figure

Top

Cite This Article

DOI: 10.3201/eid2603.190803

Original Publication Date: 2/5/2020

Table of Contents – Volume 26, Number 3—March 2020

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Isabella D.F. Gremião, Evandro Chagas National Institute of Infectious Diseases, Fiocruz, Avenida Brasil, 4365 Rio de Janeiro 21040-360, Brazil

Send To

character(s) remaining.

Comment submitted successfully, thank you for your feedback.

Top

Page created: February 20, 2020
Page updated: February 20, 2020
Page reviewed: February 20, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external